UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma

Clinical trial NCT06279026 · RECRUITING

Trial details

NCT number: NCT06279026
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2024-04-01
Primary completion: 2027-04-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.